A comprehensive annual briefing on battery materials, petrochemicals, and future industry direction
1. LG Chem 1-Year Report— Why This 1-Year Report Matters Now
This report is designed as a full “LG Chem 1-Year Review” for KORI INSIGHT WARP — a deep-dive piece capturing everything that has shaped the company over the past twelve months.
Rather than a typical stock summary, this edition looks at LG Chem from three intertwined angles:
- What actually happened during the past year (verified through announcements, business results, and market shifts)
- How the company’s multi-business portfolio is evolving
- What these changes imply for the next 1–3 years
LG Chem is not merely “a battery materials company” nor just a “petrochemical giant.”
It is now a hybrid structure built on:
- the petrochemical cycle,
- the explosive growth of battery cathode materials, and
- the long-horizon expansion of life sciences.
Understanding LG Chem properly requires seeing how these three tracks converged over the past year — and where they appear to be heading next.
NAVER 1-Year Report — A Full Review of 2024–2025 Trends, Strategy, and Market Outlook
2. Company Overview — LG Chem in Four Business Pillars
To make the next sections clearer, let’s break LG Chem into four functional pillars.
(1) Petrochemicals — The legacy backbone, now in recovery mode
LG Chem’s petrochemical division handles:
- ethylene, propylene, and base chemical feedstocks,
- polyethylene (PE), polypropylene (PP), PVC, ABS, and synthetic rubbers,
- as well as a broad range of resins used across manufacturing.
This sector is extremely cyclical.
For the past two years, oversupply from China and the Middle East depressed margins across the global industry. LG Chem spent this period adjusting operations, cutting weaker assets, and shifting toward higher-value products.
By late 2024 and into 2025, the worst appeared to have passed, showing the first signs of operational improvement.
(2) Advanced Materials — The real growth engine (Cathode Materials)
This division covers materials for EV batteries, ESS, IT, and engineering plastics.
The crown jewel is high-nickel NCM/NCMA cathode materials, plus several newer formulations targeting future EV architectures.
Key elements:
- expanding North American production bases (Tennessee plant),
- robust partnerships with Japanese and US automakers,
- a long-term shift toward precursor-less and eco-friendly cathode processing,
- scaling production for both energy-dense EV packs and long-life ESS systems.
This is the strategic pillar that will define LG Chem’s valuation going forward.
(3) Life Sciences — Small in size, big in strategic value
While smaller than petrochemicals or materials, this division offers high-margin, high-stability revenue.
Key characteristics:
- strong presence in specialty prescription drugs,
- oncology-focused pipeline via AVEO in the US,
- strategic retreat from cosmetic aesthetics to concentrate on core therapeutics.
Life sciences serve as LG Chem’s “quality enhancer,” balancing the volatility of petrochemicals and the capex-heavy nature of battery materials.
(4) Agrochemicals (FarmHannong) — A cyclical side division
This includes seeds, fertilizers, and crop protection products.
Its revenue contribution is smaller, but it occasionally boosts earnings when global agricultural cycles turn favorable.
3. A Full Timeline of LG Chem’s Last 12 Months
Below is a chronological interpretation of major events shaping LG Chem.
(1) Petrochemical downturn still weighing — early 2024
Throughout early 2024, the global petrochemical sector remained under pressure due to:
- oversupply capacity entering from China and the Middle East,
- weaker global consumption,
- margin compression across basic chemicals.
LG Chem responded by:
- shutting or restructuring less efficient facilities,
- raising the proportion of high-value chemical products,
- improving procurement efficiencies.
This period served as groundwork for later recovery.
(2) 1Q 2025 — The first credible earnings rebound
For LG Chem, 1Q 2025 stood out because:
- revenue grew slightly year-over-year,
- operating profit rose sharply,
- improvements came from better spreads + a healthier product mix.
This marked the first visible turnaround suggesting that the worst point of the petrochemical cycle had passed.
(3) InterBattery 2025 — Showcasing next-gen cathode technology
At the largest battery exhibition in Korea, LG Chem presented:
- simplified-processing cathode technologies,
- low-carbon manufacturing improvements,
- ESS-specialized materials,
- high-nickel cathode upgrades.
This helped solidify the brand’s position as not just a supplier of volume, but a supplier of advanced materials with manufacturing efficiency leadership.
(4) ESG and Circular Economy Initiatives Strengthen
In its sustainability disclosures, LG Chem highlighted:
- significant increases in PCR (post-consumer recycled) plastic adoption,
- broader circular-economy targets,
- reduced greenhouse gases across specific product lines.
This aligns with regulatory shifts in the EU, US, and Korea, reducing long-term compliance risk.
(5) 2Q 2025 — Revenue slows, profits rise
Even though top-line revenue dipped, margins improved further due to:
- chemical spread recovery,
- improved cost structures,
- resilient profitability in advanced materials and life sciences.
This is where LG Chem began showing profit resilience independent of revenue trends — a key sign of structural improvement.
(6) Strategic JV restructuring with Toyota-affiliated materials group
A Toyota-group trading unit acquired part of LG Chem’s joint venture stake, shifting:
- the supply chain footprint away from China,
- strengthening Japan–Korea materials collaboration,
- boosting US IRA compliance alignment.
This move supports LG Chem’s long-term North American strategy and secures premium customers.
(7) 3Q 2025 — A step-change in profitability
LG Chem posted Y/Y and Q/Q improvements in operating income despite modest revenue changes.
This showed:
- stabilized chemical profits,
- strong and expanding materials business,
- life sciences contributing consistent returns.
It was widely viewed as the first “earnings normalization” quarter after two years of volatility.
(8) Multi-year cathode supply contract (2025–2029)
Late in the year, LG Chem secured a multi-year, multi-trillion-won cathode materials order from a major (undisclosed) North American EV/ESS customer.
The contract suggests:
- high confidence in LG Chem’s quality and scale,
- stronger positioning in IRA-driven markets,
- structural visibility into mid-term growth.
(9) Life Sciences restructuring toward oncology specialization
By selling portions of its aesthetic medicine portfolio and steering capital toward oncology/rare-disease pipelines, LG Chem is shaping itself for:
- higher long-term ROIC,
- more predictable strategic focus,
- fewer distractions in non-core markets.
4. Financial & Performance Review — From Bottoming Out to Structural Recovery
LG Chem’s financial trajectory over the past year is best understood as a two-phase story:
(1) 2024: The trough, and
(2) 2025: A methodical climb back up.
(1) 2024 — A difficult but necessary reset year
In 2024, petrochemicals — still a crucial revenue pillar — faced some of the toughest conditions in a decade.
Industry dynamics included:
- global oversupply from China and the Middle East,
- margin collapse across commodity plastics,
- lower operating rates worldwide,
- EV sector sentiment cooling, limiting materials demand.
For LG Chem, this meant:
- tightening operational efficiency,
- reassessing underperforming assets,
- preserving CAPEX for key growth areas (battery materials & life sciences),
- focusing on cash flow stability in weaker quarters.
Although results were underwhelming, the groundwork laid in 2024 enabled LG Chem to pivot sharply once external conditions improved.
(2) 2025 — A visible shift toward operating leverage
By 2025, early signs of stabilization became clearer:
1Q 2025
- Revenue grew year-over-year.
- Operating profit surged due to improved spreads and mix upgrades.
- Inventory and cost structures became leaner.
2Q 2025
- Revenue softened (due to macro softness).
- Yet operating profit increased again, proving that LG Chem’s margin recovery was not dependent on aggressive top-line growth.
3Q 2025
- The company delivered what many analysts interpreted as the “normalization quarter.”
- Profitability was strong across advanced materials and life sciences.
- Petrochemicals finally contributed meaningful upside after nearly two years of being a drag.
In summary:
LG Chem successfully transitioned from a “volume-driven” model to a “profit-structure-driven” model — an essential shift for long-term valuation re-rating.
5. Business Segment Deep-Dive
Let’s explore each division’s strategic position and how the last 12 months have reshaped them.
(1) Petrochemicals — Slow healing, but unmistakably improving
While petrochemicals will likely never return to their 2016–2018 supercycle highs, LG Chem is positioning the segment as a steadier contributor.
Key improvements include:
- restructuring low-return lines,
- scaling high-value specialty resins,
- integrating circular-economy feedstocks,
- improving energy efficiency and cost control,
- reducing exposure to volatile naphtha margins via feedstock flexibility.
2025 outlook:
Incremental, stepwise improvement — not dramatic — but enough to stabilize earnings volatility for the group.
(2) Advanced Materials — The core of LG Chem’s future identity
The global shift toward EVs, ESS expansion, and power-grid storage is reshaping what “materials” means in modern industry.
LG Chem’s positioning is defined by:
A. North American production scaling
The Tennessee cathode plant is designed as a long-term anchor for IRA-compliant supply chains.
B. Long-term supply/contracts
Recent multi-year agreements ensure multi-billion-dollar revenue visibility.
C. Technology leadership
- precursor-free cathode innovations,
- high-nickel NCM evolution,
- processing simplification for cost and carbon reduction,
- durability-focused ESS formulations.
D. Diversified customer base
Both US and Japanese OEMs are strengthening their relationships with LG Chem, especially as supply chains move away from China.
Bottom line:
This is where LG Chem will likely generate the majority of its valuation premium for the next decade.
(3) Life Sciences — A quiet but powerful value driver
Life sciences aren’t flashy, but they demonstrate:
- stable revenue,
- expanding oncology potential,
- long-term possibility of breakout drugs,
- strategic positioning via AVEO’s US footprint.
The company’s shift away from aesthetic medicine and toward oncology and rare diseases signals a long-term focus on higher-quality therapeutic categories.
(4) Agrochemicals — Complementary, not central
Agricultural inputs fluctuate with global crop cycles, climate, and commodity prices.
LG Chem uses this division to:
- diversify revenue modestly,
- maintain exposure to stable demand sectors,
- strengthen sustainability narratives.
It’s not a major valuation driver but adds resilience at the group level.
6. Industry Landscape — The External Forces Shaping LG Chem
To understand LG Chem’s strategic positioning, we must consider three macro-industrial contexts:
(1) Petrochemical Market Dynamics
The petrochemical sector is expected to gradually recover from its severe downcycle.
Drivers include:
- slower pace of Chinese capacity additions,
- possible consolidation in oversupplied markets,
- recovering consumption tied to global GDP growth.
LG Chem’s advantage lies in its:
- wide product portfolio,
- integrated operations,
- shift toward premium and recycled chemical products.
(2) Battery Materials & EV Transition
Despite short-term sentiment softness, long-term fundamentals remain intact:
- global decarbonization laws remain unchanged,
- ICE phase-out timelines continue in Europe & parts of Asia,
- ESS storage capacity must expand for renewable energy grids.
What matters most is supply chain relocation:
- IRA restrictions,
- EU carbon-border rules,
- Japanese OEM diversification,
- global reduction of China dependence.
LG Chem is one of the very few companies globally with the scale, technology, and capital to meet this shift.
(3) Biopharma Growth Trajectory
Biopharma globally remains a structurally expanding market.
LG Chem’s oncology-first strategy gives it:
- higher long-term R&D payoff potential,
- stronger alignment with unmet medical needs,
- better margin opportunities once commercialized.
7. Outlook for the Next 1–3 Years — What the Trajectory Suggests
To evaluate LG Chem’s medium-term direction, it helps to break the outlook into three layers:
(1) the most realistic “base case,” (2) upside potential, and (3) structural risks.
(1) Base Case — Gradual, disciplined upward trajectory
This is the scenario most aligned with consensus expectations:
A. Petrochemicals
- slow but steady improvement,
- stabilized spreads,
- reduced drag on consolidated profitability.
No major supercycle is expected, but petrochemicals should stop pulling the company downward—which alone is a significant shift from 2023–2024 conditions.
B. Advanced Materials (Cathode Materials)
This remains the central value engine.
Expectations include:
- rising utilization at the Tennessee plant,
- higher contribution from North American contracts,
- ongoing improvements in production efficiency,
- stronger penetration into Japanese OEMs.
As IRA rules become more defined, LG Chem’s positioning may improve further.
C. Life Sciences
- continued revenue consistency,
- selective pipeline advancement,
- productivity increases via AVEO integration.
Over the next three years, this division is expected to mature into a reliable cash-flow component with strategic upside optionality.
(2) Upside Scenario — Catalysts that could meaningfully re-rate LG Chem’s valuation
There are three major upside triggers:
A. Stronger-than-expected EV demand recovery
If EV penetration rates accelerate again in the US, Europe, and China, cathode material orders could rise sharply.
B. New multi-year battery material contracts
LG Chem is one of the few global-scale cathode suppliers.
Additional long-term supply deals — especially with US or Japanese OEMs — would materially enhance earnings visibility.
C. Rapid optimization at North American facilities
Operating leverage from stable high-capacity utilization would dramatically boost margins.
If even two out of these three catalysts occur, LG Chem’s medium-term valuation could shift toward a higher premium range.
(3) Downside Scenario — Key risks that investors should not ignore
No company grows in a straight line.
The largest risks to monitor include:
A. EV demand volatility
- reduced subsidies,
- macroeconomic headwinds,
- inconsistent OEM production planning.
Short-term EV sentiment remains fragile.
B. Extended petrochemical oversupply
If capacity in China/Middle East continues ramping up longer than expected, global spreads may recover slowly.
C. Raw material price fluctuations
- lithium,
- nickel,
- cobalt,
- oil/naphtha.
These can pressure margins dramatically.
D. CAPEX intensity & cash flow strain
Battery materials require significant front-loaded investments.
Timing mismatches between CAPEX and earnings can temporarily compress returns.
E. Biopharma pipeline uncertainty
Clinical development timelines are inherently risky.
8. Comprehensive Risk Checklist — KORI INSIGHT WARP Format
To make things crisp, here’s a distilled risk list:
- EV macro sentiment (sales, subsidies, regulation)
- Petrochemical spread movement
- IRA regulation revisions
- North American plant utilization rate
- Lithium/nickel/cobalt price swings
- FX volatility
- CAPEX pressure vs. free cash flow timing
- Clinical pipeline milestones
This framework helps investors focus on the most material variables driving LG Chem’s 1–3 year performance.
9. “Kori’s Take” — Strategic Interpretation in Outline Form
A. How to Frame LG Chem
- LG Chem is no longer adequately described as “a chemical company.”
- Its valuation is increasingly tied to its identity as a global materials powerhouse spanning petrochemicals, cathodes, and life sciences.
B. What the Past Year Revealed
- The company is building a cross-border materials alliance with US and Japanese OEMs.
- ESG, recycling, and low-carbon cathode processing are not PR—they’re economic strategy.
C. Understanding the Two-Speed Portfolio
- Petrochemicals = cyclical stabilizer
- Cathode materials = long-term growth engine
- Life sciences = quality enhancer with asymmetric upside
D. Investment Summary in One Glance
- Short-term moves will follow EV sentiment and chemical spreads.
- Medium-term trajectory depends on North American cathode scaling.
- Long-term value comes from whether LG Chem truly becomes a materials-tech hybrid, not just a chemicals company.
10. Final Conclusion — What This 1-Year Report Ultimately Shows
When we step back and reinterpret everything that happened this year, LG Chem’s story becomes surprisingly coherent:
1) The petrochemical division has stopped being a drag.
The worst is over. Margins may not explode upward, but they are no longer collapsing. The entire organization is shifting toward specialty chemicals and recycling-driven premium products.
2) Battery materials have become the company’s true identity.
Cathode materials are not a “side business” anymore.
They represent LG Chem’s long-term valuation engine — the reason global automakers want deeper partnerships.
LG Chem is gradually transforming into a “materials-tech company anchored by cathode leadership.”
3) Life sciences provide stability and asymmetric potential.
This division reduces earnings volatility while maintaining long-term optionality through oncology pipelines. It’s a quiet but important contributor.
4) The company’s global structure has changed.
The past year revealed:
- U.S. supply chain solidification (IRA-driven)
- Stronger Japanese alliances
- Reduced exposure to China in strategic JV arrangements
- Growing presence in large-scale multi-year contracts
This is not the LG Chem of five years ago.
This is a reshaped, strategically positioned multinational materials group.
5) The next 1–3 years could redefine the company’s market perception.
If:
- North American cathode utilization rises,
- EV demand stabilizes,
- petrochemicals recover slowly but steadily,
- oncology pipelines show clinical progress,
then LG Chem has enough structural momentum to move into a new valuation range.
In essence, this 1-year period marks the beginning of LG Chem’s evolution from “a diversified chemical conglomerate” into “a future-oriented materials powerhouse.”
11. Ultra-Condensed Summary for Busy Readers
A compressed 10-point version:
- Petrochemical downturn bottomed in 2024.
- 2025 showed clear signs of profitability recovery.
- Advanced Materials is the main growth engine.
- Cathode production capabilities expanded in North America.
- Multi-year supply contracts strengthened demand visibility.
- Japanese partnerships improved supply-chain diversification.
- ESG-driven portfolio changes accelerated.
- Life sciences stabilized margins and added long-term upside.
- Risks remain: EV sentiment, raw materials, IRA policy shifts.
- LG Chem’s identity is transforming — and markets will eventually re-rate accordingly.
12. Reference Notes (LG Chem 1-Year Report)
- LG Chem annual and quarterly performance summaries
- Global petrochemical industry cycle data
- Battery materials market outlook: NCM/NCMA demand, IRA compliance shifts
- Sustainability and circular-economy disclosures
- Oncology pipeline updates (AVEO acquisition integrated data)
- EV and ESS penetration forecasts across U.S., Japan, and Europe
- Commodity pricing trends (lithium, nickel, cobalt, naphtha)
- South Korea Financial Supervisory Service (FSS)
13. Q&A (LG Chem 1-Year Report)
Q1. What was the most meaningful shift in LG Chem over the past year?
A1. The company moved from a “chemicals-first structure” toward a “materials-driven identity,” led by cathode materials, ESG-focused specialty chemicals, and oncology-centered life sciences. Petrochemicals stopped being a major drag, allowing the new growth engines to define the company’s trajectory.
Q2. What will drive LG Chem’s performance over the next 1–3 years?
A2. The key drivers include:
- utilization ramp-up of the North American cathode plant,
- additional long-term supply contracts with global automakers,
- petrochemical margin recovery,
- stable life-sciences earnings,
- strategic positioning under IRA/CBAM regulations.
Q3. What risks should investors monitor closely?
A3.
- EV demand volatility and subsidy changes,
- petrochemical oversupply risk,
- lithium/nickel/cobalt price fluctuations,
- FX and macro uncertainties,
- CAPEX-driven cash flow pressure,
- clinical trial timelines in oncology pipelines.
15. Japanese Summary
LG化学の1年間を総まとめすると、2024年の石油化学不況から回復しつつ、素材事業とバッテリー向け正極材が企業価値を大きく押し上げています。北米のIRA対応、生産拡大、長期供給契約により、中期成長の確度が高まりました。ライフサイエンス事業も安定収益を支え、腫瘍領域のパイプラインが将来の成長オプションとなります。EV需要、原材料価格、政策動向などのリスクを注視しつつ、LG化学は「化学メーカー」から「次世代素材メーカー」へ進化する重要な転換点に立っています。
#KoriInsight #LGChem #1YearReport #BatteryMaterials #Cathode #Petrochemicals #LifeSciences #EVMarket #IndustryOutlook #CorporateAnalysis
Let’s keep reading the flow behind the numbers. I’ll bring the market calmly again tomorrow — KoriInsight